IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
There are xx businesses in the Chinese Patent Drug Manufacturing industry in China, which is expected to grow at xx% over the next five years. The Chinese Patent Drug Manufacturing industry in China processes Chinese herbs to produce traditional Chinese patent medicine in capsule, powder, and liquid forms. Chinese traditional medicine pills are not manufactured by this industry (see IBISWorld industry report 2730).
Curious about what drives these trends? IBISWorld's Chinese Patent Drug Manufacturing in China industry coverage has got you covered.
Total value (#) and annual change from 2012 – 2030.
The Chinese Patent Drug Manufacturing in China Industry Report is available in multiple formats to fit seamlessly into your workflow.
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
Explore industries with similar markets, supply chains, and economic drivers to gain broader context and insights.
| Industry | Sector | Last 5-yr CAGR | Forecast 5-year CAGR | Revenue |
|---|---|---|---|---|
| Pharmaceutical Manufacturing in China |
|
XX% | XX% | $XX |
| Biological and Biochemical Product Manufacturing in China |
|
XX% | XX% | $XX |
| Chinese Medicinal Herb Growing in China |
|
XX% | XX% | $XX |
| Traditional Chinese Medicine Manufacturing in China |
|
XX% | XX% | $XX |
When the stakes are high, you need intelligence that cuts through the noise—wherever you work.
There is 1,638 Chinese Patent Drug Manufacturing in China businesses as of 2026, an increase of 0.3% from 2025.
The number of Chinese Patent Drug Manufacturing in China businesses has grown 0.3% per year on average over the five years between 2021 and 2026.
See our full analysis of the Chinese Patent Drug Manufacturing in China to understand if the mumber of bussinesses is expected to grow or decline over the next five years.
The Chinese Patent Drug Manufacturing in China has low market share concentration and the largest business is Guangzhou Pharmaceutical Holdings Limited.